Abstract:Thyroid cancer (TC) is a common malignancy of the endocrine system. Abnormal expression of tripartite motif-containing 29 (TRIM29) has been reported to promote tumorigenesis and predict poor prognosis in several human malignancies. The aim of this study was to assess the involvement of TRIM29 in the significance and prognosis of TC. Fifty-six tumor samples and their clinicopathological parameters were obtained from TC patients; the expression level of TRIM29 was detected by RT-qPCR and western blotting. TRIM29 expression was knocked down by small interfering RNA (siRNA) among TT, TPC-1, and K1 cells to investigate the biological role of TRIM29 in TC cells. The results showed that TRIM29 expression was significantly increased in TC tissue samples and cells compared to normal tissues and cells (P<0.01, respectively). Overexpression of TRIM29 was associated with TNM stage (P<0.01), extrathyroidal extension (P<0.01), lymph node metastasis (P<0.05), and distant metastasis (P<0.05). Furthermore, the overall survival and disease-free rates of patients with high TRIM29 expression were decreased significantly compared with those with low TRIM29 expression (P<0.01, respectively). Knockdown of TRIM29 obviously suppressed cell proliferation; enhanced chemosensitivity to cisplatin; inhibited cell invasion and migration; caused cell cycle arrest at G0/G1 phase by decreasing cyclin B1, cyclin D1 and CDK2, while increasing p21 and p27; and induced cell apoptosis by enhancing the activities of caspase-3, caspase-9, and Bax, while decreased Bcl-2. Notably, decreased TRIM29 expression significantly inhibited the activation of P13K/AKT signaling pathway as well. Taken together, our findings suggested that TRIM29 played a crucial role in the progression and malignancy of TC, and silencing of TRIM29 exerted its antitumor effect by blocking P13K/AKT signaling pathway. Thus, TRIM29 might be a potential therapeutic target for the treatment of TC.

Overexpression Of Trim26 Suppresses The Proliferation, Metastasis, And Glycolysis In Papillary Thyroid Carcinoma Cells

TRIM29 Promotes Progression of Thyroid Carcinoma Via Activating P13K/AKT Signaling Pathway.

Tripartite Motif Containing 14: an Oncogene in Papillary Thyroid Carcinoma.

TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis

Overexpression of ST7-AS1 Enhances Apoptosis and Inhibits Proliferation of Papillary Thyroid Carcinoma Cells Via Microrna-181B-5p-dependent Inhibition Tripartite Motif Containing 3

Suppression Of Long Noncoding Rna Linc00324 Restricts Cell Proliferation And Invasion Of Papillary Thyroid Carcinoma Through Downreguiation Of Trim29 Via Upregulating Microrna-195-5p

TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57 KIP2 repression

Downregulation of TSPAN13 by Mir-369-3p Inhibits Cell Proliferation in Papillary Thyroid Cancer (PTC)

TRIM37 promoted the growth and migration of the pancreatic cancer cells

Suppression of CCT3 Inhibits Malignant Proliferation of Human Papillary Thyroid Carcinoma Cell

Retracted Article: TRIM22 Functions As an Oncogene in Gliomas Through Regulating the Wnt/β-catenin Signaling Pathway

PRDM16 Inhibits Cell Proliferation and Migration via Epithelial-to-Mesenchymal Transition by Directly Targeting Pyruvate Carboxylase in Papillary Thyroid Cancer

TMEM252 inhibits epithelial–mesenchymal transition and progression in papillary thyroid carcinoma by regulating Notch1 expression

Downregulation of TRIM27 expression inhibits the proliferation of ovarian cancer cells in vitro and in vivo

Mir-26B-5p Inhibits the Proliferation, Migration and Invasion of Human Papillary Thyroid Cancer in a Β-Catenin-dependent Manner.

Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c-Myc-mediated glycolysis

TET1 is a Tumor Suppressor That Inhibits Papillary Thyroid Carcinoma Cell Migration and Invasion

TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells

Silencing of PPM1D inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma.

Circ_100395 Impedes Malignancy and Glycolysis in Papillary Thyroid Cancer: Involvement of PI3K/AKT/mTOR Signaling Pathway.

Overexpression of TRIM24 Stimulates Proliferation and Glucose Metabolism of Head and Neck Squamous Cell Carcinoma